nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—ABCB1—Dactinomycin—muscle cancer	0.0743	0.205	CbGbCtD
Paroxetine—CYP2C8—Etoposide—muscle cancer	0.0619	0.171	CbGbCtD
Paroxetine—CYP2B6—Doxorubicin—muscle cancer	0.0558	0.154	CbGbCtD
Paroxetine—ABCB1—Vincristine—muscle cancer	0.0457	0.126	CbGbCtD
Paroxetine—ABCB1—Etoposide—muscle cancer	0.0419	0.116	CbGbCtD
Paroxetine—ABCB1—Doxorubicin—muscle cancer	0.0286	0.0788	CbGbCtD
Paroxetine—ABCB1—Methotrexate—muscle cancer	0.0277	0.0763	CbGbCtD
Paroxetine—CYP2D6—Doxorubicin—muscle cancer	0.0269	0.0742	CbGbCtD
Paroxetine—CHRM3—muscle of abdomen—muscle cancer	0.0164	0.196	CbGeAlD
Paroxetine—HTR2A—hindlimb—muscle cancer	0.005	0.0596	CbGeAlD
Paroxetine—TACR1—smooth muscle tissue—muscle cancer	0.00459	0.0547	CbGeAlD
Paroxetine—TACR1—renal system—muscle cancer	0.00442	0.0527	CbGeAlD
Paroxetine—HTR2A—appendage—muscle cancer	0.00429	0.0511	CbGeAlD
Paroxetine—TACR1—head—muscle cancer	0.00296	0.0353	CbGeAlD
Paroxetine—TACR1—testis—muscle cancer	0.00285	0.0341	CbGeAlD
Paroxetine—CHRM4—head—muscle cancer	0.00278	0.0332	CbGeAlD
Paroxetine—CHRM4—testis—muscle cancer	0.00268	0.032	CbGeAlD
Paroxetine—CHRM5—head—muscle cancer	0.00217	0.0259	CbGeAlD
Paroxetine—CHRM3—smooth muscle tissue—muscle cancer	0.00189	0.0225	CbGeAlD
Paroxetine—CHRM3—renal system—muscle cancer	0.00182	0.0217	CbGeAlD
Paroxetine—CHRM2—head—muscle cancer	0.00149	0.0178	CbGeAlD
Paroxetine—SLC6A3—head—muscle cancer	0.00149	0.0177	CbGeAlD
Paroxetine—CYP2C8—renal system—muscle cancer	0.00147	0.0176	CbGeAlD
Paroxetine—SLC6A3—testis—muscle cancer	0.00144	0.0171	CbGeAlD
Paroxetine—HTR2A—embryo—muscle cancer	0.00142	0.017	CbGeAlD
Paroxetine—SLC6A4—head—muscle cancer	0.00136	0.0163	CbGeAlD
Paroxetine—CHRM1—head—muscle cancer	0.00136	0.0162	CbGeAlD
Paroxetine—CYP2B6—renal system—muscle cancer	0.00132	0.0158	CbGeAlD
Paroxetine—CHRM3—head—muscle cancer	0.00121	0.0145	CbGeAlD
Paroxetine—SLC6A2—head—muscle cancer	0.0012	0.0143	CbGeAlD
Paroxetine—CHRM3—testis—muscle cancer	0.00117	0.014	CbGeAlD
Paroxetine—SLC6A2—testis—muscle cancer	0.00116	0.0138	CbGeAlD
Paroxetine—HTR2A—smooth muscle tissue—muscle cancer	0.00112	0.0134	CbGeAlD
Paroxetine—HTR2A—renal system—muscle cancer	0.00108	0.0129	CbGeAlD
Paroxetine—CYP2C8—vagina—muscle cancer	0.00107	0.0127	CbGeAlD
Paroxetine—CYP2D6—renal system—muscle cancer	0.000981	0.0117	CbGeAlD
Paroxetine—CYP2B6—vagina—muscle cancer	0.000957	0.0114	CbGeAlD
Paroxetine—CYP2C8—testis—muscle cancer	0.000952	0.0114	CbGeAlD
Paroxetine—ABCB1—embryo—muscle cancer	0.000933	0.0111	CbGeAlD
Paroxetine—CYP2B6—head—muscle cancer	0.000884	0.0105	CbGeAlD
Paroxetine—CYP2B6—testis—muscle cancer	0.000854	0.0102	CbGeAlD
Paroxetine—HTR2A—tendon—muscle cancer	0.000841	0.01	CbGeAlD
Paroxetine—HTR2A—vagina—muscle cancer	0.00078	0.00931	CbGeAlD
Paroxetine—HTR2A—head—muscle cancer	0.000721	0.0086	CbGeAlD
Paroxetine—ABCB1—renal system—muscle cancer	0.000706	0.00842	CbGeAlD
Paroxetine—HTR2A—testis—muscle cancer	0.000696	0.00831	CbGeAlD
Paroxetine—CYP2D6—head—muscle cancer	0.000657	0.00783	CbGeAlD
Paroxetine—CYP2D6—testis—muscle cancer	0.000634	0.00757	CbGeAlD
Paroxetine—ABCB1—bone marrow—muscle cancer	0.000534	0.00637	CbGeAlD
Paroxetine—Asthenia—Dactinomycin—muscle cancer	0.000516	0.000932	CcSEcCtD
Paroxetine—Dysuria—Methotrexate—muscle cancer	0.000512	0.000926	CcSEcCtD
Paroxetine—ABCB1—vagina—muscle cancer	0.000511	0.0061	CbGeAlD
Paroxetine—Dehydration—Doxorubicin—muscle cancer	0.000511	0.000923	CcSEcCtD
Paroxetine—Thrombocytopenia—Etoposide—muscle cancer	0.000509	0.00092	CcSEcCtD
Paroxetine—Tachycardia—Etoposide—muscle cancer	0.000508	0.000917	CcSEcCtD
Paroxetine—Abdominal pain—Vincristine—muscle cancer	0.000508	0.000917	CcSEcCtD
Paroxetine—Body temperature increased—Vincristine—muscle cancer	0.000508	0.000917	CcSEcCtD
Paroxetine—Liver function test abnormal—Doxorubicin—muscle cancer	0.000507	0.000916	CcSEcCtD
Paroxetine—Skin disorder—Etoposide—muscle cancer	0.000505	0.000913	CcSEcCtD
Paroxetine—Erectile dysfunction—Methotrexate—muscle cancer	0.000505	0.000912	CcSEcCtD
Paroxetine—Dry skin—Doxorubicin—muscle cancer	0.000503	0.000909	CcSEcCtD
Paroxetine—Hyperhidrosis—Etoposide—muscle cancer	0.000503	0.000909	CcSEcCtD
Paroxetine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000501	0.000906	CcSEcCtD
Paroxetine—Photosensitivity reaction—Methotrexate—muscle cancer	0.0005	0.000904	CcSEcCtD
Paroxetine—Hypokalaemia—Doxorubicin—muscle cancer	0.0005	0.000903	CcSEcCtD
Paroxetine—Breast disorder—Doxorubicin—muscle cancer	0.000496	0.000896	CcSEcCtD
Paroxetine—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000494	0.000893	CcSEcCtD
Paroxetine—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000494	0.000893	CcSEcCtD
Paroxetine—Diarrhoea—Dactinomycin—muscle cancer	0.000492	0.000889	CcSEcCtD
Paroxetine—Pneumonia—Methotrexate—muscle cancer	0.000491	0.000888	CcSEcCtD
Paroxetine—Nasopharyngitis—Doxorubicin—muscle cancer	0.000491	0.000887	CcSEcCtD
Paroxetine—Drowsiness—Methotrexate—muscle cancer	0.000489	0.000883	CcSEcCtD
Paroxetine—Depression—Methotrexate—muscle cancer	0.000487	0.00088	CcSEcCtD
Paroxetine—Hypotension—Etoposide—muscle cancer	0.000486	0.000878	CcSEcCtD
Paroxetine—Gastritis—Doxorubicin—muscle cancer	0.000486	0.000878	CcSEcCtD
Paroxetine—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000484	0.000875	CcSEcCtD
Paroxetine—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000484	0.000875	CcSEcCtD
Paroxetine—Muscular weakness—Doxorubicin—muscle cancer	0.000484	0.000875	CcSEcCtD
Paroxetine—Stomatitis—Methotrexate—muscle cancer	0.000476	0.000861	CcSEcCtD
Paroxetine—Conjunctivitis—Methotrexate—muscle cancer	0.000475	0.000858	CcSEcCtD
Paroxetine—Influenza—Doxorubicin—muscle cancer	0.000474	0.000857	CcSEcCtD
Paroxetine—Asthma—Doxorubicin—muscle cancer	0.000474	0.000857	CcSEcCtD
Paroxetine—Dysphagia—Doxorubicin—muscle cancer	0.000474	0.000857	CcSEcCtD
Paroxetine—Hypersensitivity—Vincristine—muscle cancer	0.000473	0.000855	CcSEcCtD
Paroxetine—ABCB1—head—muscle cancer	0.000472	0.00564	CbGeAlD
Paroxetine—Eosinophilia—Doxorubicin—muscle cancer	0.00047	0.000849	CcSEcCtD
Paroxetine—Sweating—Methotrexate—muscle cancer	0.000468	0.000846	CcSEcCtD
Paroxetine—Paraesthesia—Etoposide—muscle cancer	0.000467	0.000844	CcSEcCtD
Paroxetine—Haematuria—Methotrexate—muscle cancer	0.000466	0.000842	CcSEcCtD
Paroxetine—Pancreatitis—Doxorubicin—muscle cancer	0.000465	0.000841	CcSEcCtD
Paroxetine—Dyspnoea—Etoposide—muscle cancer	0.000464	0.000838	CcSEcCtD
Paroxetine—Somnolence—Etoposide—muscle cancer	0.000462	0.000836	CcSEcCtD
Paroxetine—Angina pectoris—Doxorubicin—muscle cancer	0.000462	0.000835	CcSEcCtD
Paroxetine—Hepatobiliary disease—Methotrexate—muscle cancer	0.000462	0.000835	CcSEcCtD
Paroxetine—Epistaxis—Methotrexate—muscle cancer	0.000461	0.000833	CcSEcCtD
Paroxetine—Asthenia—Vincristine—muscle cancer	0.000461	0.000833	CcSEcCtD
Paroxetine—Vomiting—Dactinomycin—muscle cancer	0.000457	0.000826	CcSEcCtD
Paroxetine—Bronchitis—Doxorubicin—muscle cancer	0.000456	0.000825	CcSEcCtD
Paroxetine—ABCB1—testis—muscle cancer	0.000456	0.00544	CbGeAlD
Paroxetine—Agranulocytosis—Methotrexate—muscle cancer	0.000456	0.000824	CcSEcCtD
Paroxetine—Rash—Dactinomycin—muscle cancer	0.000453	0.000819	CcSEcCtD
Paroxetine—Decreased appetite—Etoposide—muscle cancer	0.000452	0.000817	CcSEcCtD
Paroxetine—Pancytopenia—Doxorubicin—muscle cancer	0.000451	0.000814	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000449	0.000812	CcSEcCtD
Paroxetine—Fatigue—Etoposide—muscle cancer	0.000449	0.00081	CcSEcCtD
Paroxetine—Pain—Etoposide—muscle cancer	0.000445	0.000804	CcSEcCtD
Paroxetine—Constipation—Etoposide—muscle cancer	0.000445	0.000804	CcSEcCtD
Paroxetine—Dysuria—Doxorubicin—muscle cancer	0.000444	0.000802	CcSEcCtD
Paroxetine—Haemoglobin—Methotrexate—muscle cancer	0.000441	0.000797	CcSEcCtD
Paroxetine—Diarrhoea—Vincristine—muscle cancer	0.000439	0.000794	CcSEcCtD
Paroxetine—Haemorrhage—Methotrexate—muscle cancer	0.000439	0.000793	CcSEcCtD
Paroxetine—Hepatitis—Methotrexate—muscle cancer	0.000439	0.000793	CcSEcCtD
Paroxetine—Pollakiuria—Doxorubicin—muscle cancer	0.000438	0.000792	CcSEcCtD
Paroxetine—Pharyngitis—Methotrexate—muscle cancer	0.000435	0.000787	CcSEcCtD
Paroxetine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000433	0.000783	CcSEcCtD
Paroxetine—Weight increased—Doxorubicin—muscle cancer	0.000432	0.00078	CcSEcCtD
Paroxetine—Weight decreased—Doxorubicin—muscle cancer	0.000429	0.000776	CcSEcCtD
Paroxetine—Feeling abnormal—Etoposide—muscle cancer	0.000429	0.000775	CcSEcCtD
Paroxetine—Hyperglycaemia—Doxorubicin—muscle cancer	0.000428	0.000773	CcSEcCtD
Paroxetine—Nausea—Dactinomycin—muscle cancer	0.000427	0.000772	CcSEcCtD
Paroxetine—Pneumonia—Doxorubicin—muscle cancer	0.000426	0.000769	CcSEcCtD
Paroxetine—Gastrointestinal pain—Etoposide—muscle cancer	0.000425	0.000769	CcSEcCtD
Paroxetine—Dizziness—Vincristine—muscle cancer	0.000425	0.000767	CcSEcCtD
Paroxetine—Drowsiness—Doxorubicin—muscle cancer	0.000423	0.000764	CcSEcCtD
Paroxetine—Visual impairment—Methotrexate—muscle cancer	0.000423	0.000764	CcSEcCtD
Paroxetine—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000419	0.000758	CcSEcCtD
Paroxetine—Erythema multiforme—Methotrexate—muscle cancer	0.000415	0.000749	CcSEcCtD
Paroxetine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000415	0.000749	CcSEcCtD
Paroxetine—Urticaria—Etoposide—muscle cancer	0.000413	0.000747	CcSEcCtD
Paroxetine—Jaundice—Doxorubicin—muscle cancer	0.000412	0.000745	CcSEcCtD
Paroxetine—Stomatitis—Doxorubicin—muscle cancer	0.000412	0.000745	CcSEcCtD
Paroxetine—Abdominal pain—Etoposide—muscle cancer	0.000411	0.000743	CcSEcCtD
Paroxetine—Body temperature increased—Etoposide—muscle cancer	0.000411	0.000743	CcSEcCtD
Paroxetine—Urinary tract infection—Doxorubicin—muscle cancer	0.000411	0.000743	CcSEcCtD
Paroxetine—Conjunctivitis—Doxorubicin—muscle cancer	0.000411	0.000743	CcSEcCtD
Paroxetine—Eye disorder—Methotrexate—muscle cancer	0.00041	0.000741	CcSEcCtD
Paroxetine—Tinnitus—Methotrexate—muscle cancer	0.000409	0.000739	CcSEcCtD
Paroxetine—Vomiting—Vincristine—muscle cancer	0.000408	0.000738	CcSEcCtD
Paroxetine—Cardiac disorder—Methotrexate—muscle cancer	0.000407	0.000736	CcSEcCtD
Paroxetine—Sweating—Doxorubicin—muscle cancer	0.000406	0.000733	CcSEcCtD
Paroxetine—Rash—Vincristine—muscle cancer	0.000405	0.000732	CcSEcCtD
Paroxetine—Dermatitis—Vincristine—muscle cancer	0.000405	0.000731	CcSEcCtD
Paroxetine—Haematuria—Doxorubicin—muscle cancer	0.000403	0.000729	CcSEcCtD
Paroxetine—Headache—Vincristine—muscle cancer	0.000402	0.000727	CcSEcCtD
Paroxetine—Hepatobiliary disease—Doxorubicin—muscle cancer	0.0004	0.000723	CcSEcCtD
Paroxetine—Epistaxis—Doxorubicin—muscle cancer	0.000399	0.000721	CcSEcCtD
Paroxetine—Angiopathy—Methotrexate—muscle cancer	0.000398	0.000719	CcSEcCtD
Paroxetine—Sinusitis—Doxorubicin—muscle cancer	0.000397	0.000717	CcSEcCtD
Paroxetine—Immune system disorder—Methotrexate—muscle cancer	0.000396	0.000716	CcSEcCtD
Paroxetine—Mediastinal disorder—Methotrexate—muscle cancer	0.000395	0.000714	CcSEcCtD
Paroxetine—Agranulocytosis—Doxorubicin—muscle cancer	0.000395	0.000713	CcSEcCtD
Paroxetine—Chills—Methotrexate—muscle cancer	0.000394	0.000711	CcSEcCtD
Paroxetine—Alopecia—Methotrexate—muscle cancer	0.000388	0.0007	CcSEcCtD
Paroxetine—Bradycardia—Doxorubicin—muscle cancer	0.000387	0.000699	CcSEcCtD
Paroxetine—Mental disorder—Methotrexate—muscle cancer	0.000384	0.000694	CcSEcCtD
Paroxetine—Hypersensitivity—Etoposide—muscle cancer	0.000383	0.000693	CcSEcCtD
Paroxetine—Malnutrition—Methotrexate—muscle cancer	0.000382	0.00069	CcSEcCtD
Paroxetine—Erythema—Methotrexate—muscle cancer	0.000382	0.00069	CcSEcCtD
Paroxetine—Haemoglobin—Doxorubicin—muscle cancer	0.000382	0.00069	CcSEcCtD
Paroxetine—Nausea—Vincristine—muscle cancer	0.000381	0.000689	CcSEcCtD
Paroxetine—Rhinitis—Doxorubicin—muscle cancer	0.000381	0.000688	CcSEcCtD
Paroxetine—Haemorrhage—Doxorubicin—muscle cancer	0.00038	0.000686	CcSEcCtD
Paroxetine—Hepatitis—Doxorubicin—muscle cancer	0.00038	0.000686	CcSEcCtD
Paroxetine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000378	0.000683	CcSEcCtD
Paroxetine—Pharyngitis—Doxorubicin—muscle cancer	0.000377	0.000681	CcSEcCtD
Paroxetine—Oedema peripheral—Doxorubicin—muscle cancer	0.000374	0.000676	CcSEcCtD
Paroxetine—Dysgeusia—Methotrexate—muscle cancer	0.000374	0.000676	CcSEcCtD
Paroxetine—Asthenia—Etoposide—muscle cancer	0.000373	0.000674	CcSEcCtD
Paroxetine—Connective tissue disorder—Doxorubicin—muscle cancer	0.000373	0.000674	CcSEcCtD
Paroxetine—Back pain—Methotrexate—muscle cancer	0.000369	0.000667	CcSEcCtD
Paroxetine—Pruritus—Etoposide—muscle cancer	0.000368	0.000665	CcSEcCtD
Paroxetine—Visual impairment—Doxorubicin—muscle cancer	0.000366	0.000661	CcSEcCtD
Paroxetine—Vision blurred—Methotrexate—muscle cancer	0.00036	0.00065	CcSEcCtD
Paroxetine—Erythema multiforme—Doxorubicin—muscle cancer	0.000359	0.000649	CcSEcCtD
Paroxetine—Diarrhoea—Etoposide—muscle cancer	0.000356	0.000643	CcSEcCtD
Paroxetine—Eye disorder—Doxorubicin—muscle cancer	0.000355	0.000641	CcSEcCtD
Paroxetine—Ill-defined disorder—Methotrexate—muscle cancer	0.000354	0.00064	CcSEcCtD
Paroxetine—Tinnitus—Doxorubicin—muscle cancer	0.000354	0.00064	CcSEcCtD
Paroxetine—Anaemia—Methotrexate—muscle cancer	0.000353	0.000638	CcSEcCtD
Paroxetine—Flushing—Doxorubicin—muscle cancer	0.000352	0.000637	CcSEcCtD
Paroxetine—Cardiac disorder—Doxorubicin—muscle cancer	0.000352	0.000637	CcSEcCtD
Paroxetine—Angiopathy—Doxorubicin—muscle cancer	0.000345	0.000623	CcSEcCtD
Paroxetine—Malaise—Methotrexate—muscle cancer	0.000344	0.000622	CcSEcCtD
Paroxetine—Dizziness—Etoposide—muscle cancer	0.000344	0.000622	CcSEcCtD
Paroxetine—Immune system disorder—Doxorubicin—muscle cancer	0.000343	0.00062	CcSEcCtD
Paroxetine—Vertigo—Methotrexate—muscle cancer	0.000343	0.00062	CcSEcCtD
Paroxetine—Mediastinal disorder—Doxorubicin—muscle cancer	0.000342	0.000619	CcSEcCtD
Paroxetine—Leukopenia—Methotrexate—muscle cancer	0.000342	0.000618	CcSEcCtD
Paroxetine—Chills—Doxorubicin—muscle cancer	0.000341	0.000616	CcSEcCtD
Paroxetine—Arrhythmia—Doxorubicin—muscle cancer	0.000339	0.000613	CcSEcCtD
Paroxetine—Alopecia—Doxorubicin—muscle cancer	0.000336	0.000606	CcSEcCtD
Paroxetine—Cough—Methotrexate—muscle cancer	0.000333	0.000602	CcSEcCtD
Paroxetine—Mental disorder—Doxorubicin—muscle cancer	0.000333	0.000601	CcSEcCtD
Paroxetine—Convulsion—Methotrexate—muscle cancer	0.000331	0.000598	CcSEcCtD
Paroxetine—Vomiting—Etoposide—muscle cancer	0.000331	0.000598	CcSEcCtD
Paroxetine—Erythema—Doxorubicin—muscle cancer	0.000331	0.000597	CcSEcCtD
Paroxetine—Malnutrition—Doxorubicin—muscle cancer	0.000331	0.000597	CcSEcCtD
Paroxetine—Rash—Etoposide—muscle cancer	0.000328	0.000593	CcSEcCtD
Paroxetine—Dermatitis—Etoposide—muscle cancer	0.000328	0.000592	CcSEcCtD
Paroxetine—Headache—Etoposide—muscle cancer	0.000326	0.000589	CcSEcCtD
Paroxetine—Flatulence—Doxorubicin—muscle cancer	0.000326	0.000589	CcSEcCtD
Paroxetine—Myalgia—Methotrexate—muscle cancer	0.000325	0.000587	CcSEcCtD
Paroxetine—Chest pain—Methotrexate—muscle cancer	0.000325	0.000587	CcSEcCtD
Paroxetine—Arthralgia—Methotrexate—muscle cancer	0.000325	0.000587	CcSEcCtD
Paroxetine—Tension—Doxorubicin—muscle cancer	0.000324	0.000586	CcSEcCtD
Paroxetine—Dysgeusia—Doxorubicin—muscle cancer	0.000324	0.000585	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000323	0.000583	CcSEcCtD
Paroxetine—Discomfort—Methotrexate—muscle cancer	0.000321	0.00058	CcSEcCtD
Paroxetine—Nervousness—Doxorubicin—muscle cancer	0.000321	0.00058	CcSEcCtD
Paroxetine—Back pain—Doxorubicin—muscle cancer	0.00032	0.000578	CcSEcCtD
Paroxetine—Muscle spasms—Doxorubicin—muscle cancer	0.000318	0.000574	CcSEcCtD
Paroxetine—Confusional state—Methotrexate—muscle cancer	0.000314	0.000568	CcSEcCtD
Paroxetine—Anaphylactic shock—Methotrexate—muscle cancer	0.000312	0.000563	CcSEcCtD
Paroxetine—Vision blurred—Doxorubicin—muscle cancer	0.000312	0.000563	CcSEcCtD
Paroxetine—Infection—Methotrexate—muscle cancer	0.00031	0.000559	CcSEcCtD
Paroxetine—Nausea—Etoposide—muscle cancer	0.000309	0.000558	CcSEcCtD
Paroxetine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000307	0.000554	CcSEcCtD
Paroxetine—Nervous system disorder—Methotrexate—muscle cancer	0.000306	0.000552	CcSEcCtD
Paroxetine—Anaemia—Doxorubicin—muscle cancer	0.000306	0.000552	CcSEcCtD
Paroxetine—Thrombocytopenia—Methotrexate—muscle cancer	0.000305	0.000551	CcSEcCtD
Paroxetine—Agitation—Doxorubicin—muscle cancer	0.000304	0.000549	CcSEcCtD
Paroxetine—Skin disorder—Methotrexate—muscle cancer	0.000303	0.000547	CcSEcCtD
Paroxetine—Hyperhidrosis—Methotrexate—muscle cancer	0.000301	0.000544	CcSEcCtD
Paroxetine—Malaise—Doxorubicin—muscle cancer	0.000298	0.000539	CcSEcCtD
Paroxetine—Vertigo—Doxorubicin—muscle cancer	0.000297	0.000537	CcSEcCtD
Paroxetine—Syncope—Doxorubicin—muscle cancer	0.000296	0.000536	CcSEcCtD
Paroxetine—Leukopenia—Doxorubicin—muscle cancer	0.000296	0.000535	CcSEcCtD
Paroxetine—Palpitations—Doxorubicin—muscle cancer	0.000292	0.000528	CcSEcCtD
Paroxetine—Hypotension—Methotrexate—muscle cancer	0.000291	0.000526	CcSEcCtD
Paroxetine—Loss of consciousness—Doxorubicin—muscle cancer	0.000291	0.000525	CcSEcCtD
Paroxetine—Cough—Doxorubicin—muscle cancer	0.000289	0.000521	CcSEcCtD
Paroxetine—Convulsion—Doxorubicin—muscle cancer	0.000286	0.000518	CcSEcCtD
Paroxetine—Hypertension—Doxorubicin—muscle cancer	0.000285	0.000516	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000284	0.000513	CcSEcCtD
Paroxetine—Insomnia—Methotrexate—muscle cancer	0.000282	0.000509	CcSEcCtD
Paroxetine—Arthralgia—Doxorubicin—muscle cancer	0.000281	0.000509	CcSEcCtD
Paroxetine—Chest pain—Doxorubicin—muscle cancer	0.000281	0.000509	CcSEcCtD
Paroxetine—Myalgia—Doxorubicin—muscle cancer	0.000281	0.000509	CcSEcCtD
Paroxetine—Anxiety—Doxorubicin—muscle cancer	0.000281	0.000507	CcSEcCtD
Paroxetine—Paraesthesia—Methotrexate—muscle cancer	0.00028	0.000506	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00028	0.000505	CcSEcCtD
Paroxetine—Discomfort—Doxorubicin—muscle cancer	0.000278	0.000503	CcSEcCtD
Paroxetine—Dyspnoea—Methotrexate—muscle cancer	0.000278	0.000502	CcSEcCtD
Paroxetine—Somnolence—Methotrexate—muscle cancer	0.000277	0.000501	CcSEcCtD
Paroxetine—Dry mouth—Doxorubicin—muscle cancer	0.000275	0.000497	CcSEcCtD
Paroxetine—Dyspepsia—Methotrexate—muscle cancer	0.000274	0.000496	CcSEcCtD
Paroxetine—Confusional state—Doxorubicin—muscle cancer	0.000272	0.000492	CcSEcCtD
Paroxetine—Decreased appetite—Methotrexate—muscle cancer	0.000271	0.000489	CcSEcCtD
Paroxetine—Anaphylactic shock—Doxorubicin—muscle cancer	0.00027	0.000488	CcSEcCtD
Paroxetine—Oedema—Doxorubicin—muscle cancer	0.00027	0.000488	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000269	0.000486	CcSEcCtD
Paroxetine—Fatigue—Methotrexate—muscle cancer	0.000269	0.000485	CcSEcCtD
Paroxetine—Infection—Doxorubicin—muscle cancer	0.000268	0.000484	CcSEcCtD
Paroxetine—Pain—Methotrexate—muscle cancer	0.000266	0.000482	CcSEcCtD
Paroxetine—Shock—Doxorubicin—muscle cancer	0.000265	0.00048	CcSEcCtD
Paroxetine—Nervous system disorder—Doxorubicin—muscle cancer	0.000265	0.000478	CcSEcCtD
Paroxetine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000264	0.000477	CcSEcCtD
Paroxetine—Tachycardia—Doxorubicin—muscle cancer	0.000263	0.000476	CcSEcCtD
Paroxetine—Skin disorder—Doxorubicin—muscle cancer	0.000262	0.000474	CcSEcCtD
Paroxetine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000261	0.000471	CcSEcCtD
Paroxetine—Feeling abnormal—Methotrexate—muscle cancer	0.000257	0.000464	CcSEcCtD
Paroxetine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000255	0.00046	CcSEcCtD
Paroxetine—Hypotension—Doxorubicin—muscle cancer	0.000252	0.000456	CcSEcCtD
Paroxetine—Urticaria—Methotrexate—muscle cancer	0.000248	0.000447	CcSEcCtD
Paroxetine—Abdominal pain—Methotrexate—muscle cancer	0.000246	0.000445	CcSEcCtD
Paroxetine—Body temperature increased—Methotrexate—muscle cancer	0.000246	0.000445	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000246	0.000444	CcSEcCtD
Paroxetine—Insomnia—Doxorubicin—muscle cancer	0.000244	0.000441	CcSEcCtD
Paroxetine—Paraesthesia—Doxorubicin—muscle cancer	0.000242	0.000438	CcSEcCtD
Paroxetine—Dyspnoea—Doxorubicin—muscle cancer	0.000241	0.000435	CcSEcCtD
Paroxetine—Somnolence—Doxorubicin—muscle cancer	0.00024	0.000433	CcSEcCtD
Paroxetine—Dyspepsia—Doxorubicin—muscle cancer	0.000238	0.000429	CcSEcCtD
Paroxetine—Decreased appetite—Doxorubicin—muscle cancer	0.000235	0.000424	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000233	0.000421	CcSEcCtD
Paroxetine—Fatigue—Doxorubicin—muscle cancer	0.000233	0.00042	CcSEcCtD
Paroxetine—Constipation—Doxorubicin—muscle cancer	0.000231	0.000417	CcSEcCtD
Paroxetine—Pain—Doxorubicin—muscle cancer	0.000231	0.000417	CcSEcCtD
Paroxetine—Hypersensitivity—Methotrexate—muscle cancer	0.00023	0.000415	CcSEcCtD
Paroxetine—Asthenia—Methotrexate—muscle cancer	0.000224	0.000404	CcSEcCtD
Paroxetine—Feeling abnormal—Doxorubicin—muscle cancer	0.000222	0.000402	CcSEcCtD
Paroxetine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000221	0.000399	CcSEcCtD
Paroxetine—Pruritus—Methotrexate—muscle cancer	0.00022	0.000398	CcSEcCtD
Paroxetine—Urticaria—Doxorubicin—muscle cancer	0.000214	0.000387	CcSEcCtD
Paroxetine—Abdominal pain—Doxorubicin—muscle cancer	0.000213	0.000385	CcSEcCtD
Paroxetine—Body temperature increased—Doxorubicin—muscle cancer	0.000213	0.000385	CcSEcCtD
Paroxetine—Diarrhoea—Methotrexate—muscle cancer	0.000213	0.000385	CcSEcCtD
Paroxetine—Dizziness—Methotrexate—muscle cancer	0.000206	0.000372	CcSEcCtD
Paroxetine—Hypersensitivity—Doxorubicin—muscle cancer	0.000199	0.000359	CcSEcCtD
Paroxetine—Vomiting—Methotrexate—muscle cancer	0.000198	0.000358	CcSEcCtD
Paroxetine—Rash—Methotrexate—muscle cancer	0.000196	0.000355	CcSEcCtD
Paroxetine—Dermatitis—Methotrexate—muscle cancer	0.000196	0.000355	CcSEcCtD
Paroxetine—Headache—Methotrexate—muscle cancer	0.000195	0.000353	CcSEcCtD
Paroxetine—Asthenia—Doxorubicin—muscle cancer	0.000194	0.00035	CcSEcCtD
Paroxetine—Pruritus—Doxorubicin—muscle cancer	0.000191	0.000345	CcSEcCtD
Paroxetine—Nausea—Methotrexate—muscle cancer	0.000185	0.000334	CcSEcCtD
Paroxetine—Diarrhoea—Doxorubicin—muscle cancer	0.000185	0.000334	CcSEcCtD
Paroxetine—Dizziness—Doxorubicin—muscle cancer	0.000178	0.000322	CcSEcCtD
Paroxetine—Vomiting—Doxorubicin—muscle cancer	0.000172	0.00031	CcSEcCtD
Paroxetine—Rash—Doxorubicin—muscle cancer	0.00017	0.000307	CcSEcCtD
Paroxetine—Dermatitis—Doxorubicin—muscle cancer	0.00017	0.000307	CcSEcCtD
Paroxetine—Headache—Doxorubicin—muscle cancer	0.000169	0.000305	CcSEcCtD
Paroxetine—Nausea—Doxorubicin—muscle cancer	0.00016	0.00029	CcSEcCtD
